Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 587-591 , July 2010

SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain

  • Kelly P. Cosgrove

      Affiliations

    • Yale University School of Medicine, VA Connecticut HCS (116A6), West Haven, CT 06516, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 203 932 5711x3329; fax: +1 203 937 3897.
    • ,
  • Julie K. Staley

      Affiliations

    • Yale University School of Medicine, VA Connecticut HCS (116A6), West Haven, CT 06516, USA
    • ,
  • Ronald M. Baldwin

      Affiliations

    • Yale University School of Medicine, VA Connecticut HCS (116A6), West Haven, CT 06516, USA
    • ,
  • Frederic Bois

      Affiliations

    • Yale University School of Medicine, VA Connecticut HCS (116A6), West Haven, CT 06516, USA
    • ,
  • Christophe Plisson

      Affiliations

    • Emory University School of Medicine, Atlanta, GA 30322, USA
    • ,
  • Mohammed S. Al-Tikriti

      Affiliations

    • Yale University School of Medicine, VA Connecticut HCS (116A6), West Haven, CT 06516, USA
    • ,
  • John P. Seibyl

      Affiliations

    • Institute for Neurodegenerative Disorders, New Haven, CT 06510, USA
    • ,
  • Mark M. Goodman

      Affiliations

    • Emory University School of Medicine, Atlanta, GA 30322, USA
    • ,
  • Gilles D. Tamagnan

      Affiliations

    • Yale University School of Medicine, VA Connecticut HCS (116A6), West Haven, CT 06516, USA
    • Institute for Neurodegenerative Disorders, New Haven, CT 06510, USA

Received 25 January 2010 ,Revised 4 March 2010 ,Accepted 26 March 2010.

References 

  1. Staley JK, Malison RT, Innis RB. Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry. 1998;44:534–549
  2. Furmark T. Neurobiological aspects of social anxiety disorder. Isr J Psychiatry Relat Sci. 2009;46:5–12
  3. Geyer MA, Vollenweider FX. Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci. 2008;29:445–453
  4. Vengeliene V, Bilbao A, Molander A, Spanagel R. Neuropharmacology of alcohol addiction. Br J Pharmacol. 2008;154:299–315
  5. Staley JK, Sanacora G, Tamagnan G, Maciejewski PK, Malison RT, Berman RM, et al. Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry. 2006;59:40–47
  6. Kugaya A, Sanacora G, Staley JK, Malison RT, Bozkurt A, Khan S, et al. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biol Psychiatry. 2004;56:497–502
  7. van der Wee NJ, van Veen JF, Stevens H, van Vliet IM, van Rijk PP, Westenberg HG. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med. 2008;49:757–763
  8. Jacobsen LK, Staley JK, Malison RT, Zoghbi SS, Seibyl JP, Kosten TR, et al. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry. 2000;157:1134–1140
  9. Cosgrove KP, Krantzler E, Frohlich EB, Stiklus S, Pittman B, Tamagnan GD, et al. Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking. Neuropsychopharmacology. 2009;34:2218–2226
  10. Bergstrom K, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn C, et al. In vitro and in vivo characterization of nor-Δ-CIT: a potential radioligand for visualization of the serotonin transporter in the brain. Eur J Nucl Med. 1997;24:596–601
  11. Hiltunen J, Akerman KK, Kuikka JT, Bergstrom KA, Halldin C, Nikula T, et al. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Eur J Nucl Med. 1998;25:19–23
  12. Talbot PS, Bradley S, Clarke CP, Babalola KO, Philipp AW, Brown G, et al. Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans. Neuropsychopharmacology. 2009;35:741–751
  13. Hammoud DA, Endres CJ, Hammond E, Uzuner O, Brown A, Nath A, et al. Imaging serotonergic transmission with [(11)C]DASB-PET in depressed and non-depressed patients infected with HIV. NeuroImage. 2009;49:2588–2595
  14. Henningsson S, Borg J, Lundberg J, Bah J, Lindstrom M, Ryding E, et al. Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men. Biol Psychiatry. 2009;66:477–485
  15. Jovanovic H, Karlsson P, Cerin A, Halldin C, Nordstrom AL. 5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET. Psychiatry Res. 2009;172:31–37
  16. Lundgren JD, Newberg AB, Allison KC, Wintering NA, Ploessl K, Stunkard AJ. 123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: a preliminary report. Psychiatry Res. 2008;162:214–220
  17. Koch W, Schaaff N, Popperl G, Mulert C, Juckel G, Reicherzer M, et al. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. J Psychiatry Neurosci. 2007;32:234–240
  18. Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, et al. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4′-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. J Med Chem. 2003;46:925–935
  19. Staley J, Tamagnan G, Baldwin R, Fujita M, Tikriti MA, Eshima L, et al. SPECT imaging with the D4 receptor antagonist L-750,667 in nonhuman primate brain. Nucl Med Biol. 2000;27:547–556

☆ This research was sponsored by the US Department of Veterans Affairs [Schizophrenia Research Center, Research Enhancement Award Program (REAP) Center on “Neural Mechanisms and Treatment Response in Depression”], the Office of Health and Environmental Research, the US Department of Energy under Grant No. DE-FG02-97ER62637, NARSAD and National Institutes of Health grants KO1 DA020651 and KO1 AA00288.

PII: S0969-8051(10)00064-8

doi: 10.1016/j.nucmedbio.2010.03.007

Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 587-591 , July 2010

Article Tools

* Image Usage & Resolution